Efficacy and Safety of Transarterial Chemoembolization Plus Donafenib with or without Immune Checkpoint Inhibitors as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Deng L, Sun Y, Wang H, Liao C, Li D, Xu G, Yang X

Journal of Hepatocellular Carcinoma 2024, 11:29-38

Published Date: 9 January 2024